
Sign up to save your podcasts
Or
In this episode we talk about the results of the CRASH-2 trial published in Lancet. This trial showed that the EARLY use of Tranexamic acid may improve survivial, but delayed use may be associated with an increased mortality.
4.8
649649 ratings
In this episode we talk about the results of the CRASH-2 trial published in Lancet. This trial showed that the EARLY use of Tranexamic acid may improve survivial, but delayed use may be associated with an increased mortality.
938 Listeners
1,072 Listeners
893 Listeners
393 Listeners
11,313 Listeners
63,451 Listeners
2,865 Listeners
3,919 Listeners
1,531 Listeners
1,865 Listeners
324 Listeners
257 Listeners
8,220 Listeners
247 Listeners
219 Listeners